Article
FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma
1 Apr 2024
Abstract excerpt
The wide application of RNA sequencing in clinical practice has allowed the discovery of novel fusion genes, which have contributed to a refined molecular classification of rhabdomyosarcoma (RMS). Most fusions in RMS result in aberrant transcription factors, such as PAX3/7::FOXO1 in alveolar RMS (ARMS) and fusions involving VGLL2 or NCOA2 in infantile spindle cell RMS. However, recurrent fusions driving oncogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
